Boryung Corporation

KOSE:A003850 Stock Report

Market Cap: ₩688.3b

Boryung Balance Sheet Health

Financial Health criteria checks 6/6

Boryung has a total shareholder equity of ₩590.2B and total debt of ₩203.3B, which brings its debt-to-equity ratio to 34.4%. Its total assets and total liabilities are ₩1,029.7B and ₩439.5B respectively. Boryung's EBIT is ₩69.1B making its interest coverage ratio 8. It has cash and short-term investments of ₩29.1B.

Key information

34.4%

Debt to equity ratio

₩203.26b

Debt

Interest coverage ratio8x
Cash₩29.10b
Equity₩590.17b
Total liabilities₩439.48b
Total assets₩1.03t

Recent financial health updates

Recent updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Sep 20
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Aug 05
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Apr 06
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Apr 28
A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Feb 27
Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09
Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25
Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23
Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Financial Position Analysis

Short Term Liabilities: A003850's short term assets (₩491.1B) exceed its short term liabilities (₩288.2B).

Long Term Liabilities: A003850's short term assets (₩491.1B) exceed its long term liabilities (₩151.3B).


Debt to Equity History and Analysis

Debt Level: A003850's net debt to equity ratio (29.5%) is considered satisfactory.

Reducing Debt: A003850's debt to equity ratio has reduced from 36.5% to 34.4% over the past 5 years.

Debt Coverage: A003850's debt is well covered by operating cash flow (31.2%).

Interest Coverage: A003850's interest payments on its debt are well covered by EBIT (8x coverage).


Balance Sheet


Discover healthy companies